Johnson & Johnson mentioned Tuesday it had agreed to purchase heart-device maker Abiomed Inc. in an all-cash deal that will be valued at $16.6 billion upfront together with money.
Supply: Live Mint
Johnson & Johnson mentioned Tuesday it had agreed to purchase heart-device maker Abiomed Inc. in an all-cash deal that will be valued at $16.6 billion upfront together with money.
Supply: Live Mint
[mc4wp_form id=”158″]
© 2021 Success News - Developed by Sawah Web.
© 2021 Success News - Developed by Sawah Web.